Loading…
Godavari Drugs (BSE 530317)₹121.00−0.12%Pharmaceuticals
Godavari Drugs is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 24.2 against a peer median of 20.2, and ROCE of 7.0% against a peer median of 10.0%, and latest-quarter sales growth of 30.1% against a peer median of 27.4%. By market cap it is #9 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Speciality Medicines | 136 | 10.4 | 25.0 | 25.5 | 0.09 | 0.0 | 75 | 13 | 45.2 | 166.1 | vs BSE 530317 |
| Parnax Lab | 134 | 15.0 | 14.0 | 14.4 | 0.87 | 0.0 | 249 | 12 | 6.4 | −86.6 | vs BSE 530317 |
| Bal Pharma | 132 | 18.6 | 10.0 | 7.9 | 1.96 | 1.4 | 313 | 6 | 34.5 | 460.0 | vs BSE 530317 |
| Lactose (India) | 132 | 21.9 | 11.1 | 9.8 | 0.96 | 0.0 | 163 | 6 | 64.9 | 190.8 | vs BSE 530317 |
| Krebs Biochemicals and Industries | 129 | — | −15.0 | — | — | 0.0 | 24 | −17 | 27.4 | — | vs BSE 530317 |
| Asston Pharmaceuticals | 129 | 33.3 | 16.8 | 15.5 | 0.13 | 0.0 | 25 | 4 | 10.8 | −75.8 | vs BSE 530317 |
| BALAXI PHARMACEUTICALS | 125 | 55.3 | 3.0 | 0.6 | 0.23 | 0.0 | 270 | 1 | 14.1 | 336.7 | vs BSE 530317 |
| Parnax Lab | 125 | 14.0 | 14.1 | 14.4 | 0.87 | 0.0 | 249 | 12 | 6.4 | −86.6 | vs BSE 530317 |
| Godavari Drugs | 122 | 24.2 | 7.0 | 6.4 | 1.00 | 0.0 | 106 | 4 | 30.1 | 45.5 | — |
| Alpa Laboratories | 119 | 28.6 | 9.1 | 8.3 | 0.02 | 0.0 | 106 | 15 | 25.3 | −91.6 | vs BSE 530317 |
| Makers Laboratories | 111 | 14.9 | 9.0 | 3.2 | 0.05 | 0.0 | 141 | 8 | 41.0 | 1,064.4 | vs BSE 530317 |
| Peer median | 129 | 20.2 | 10.0 | 9.1 | 0.55 | 0.0 | 141 | 6 | 27.4 | 105.8 |
Listed companies closest to Godavari Drugs in Pharmaceuticals include Speciality Medicines, Parnax Lab, Bal Pharma, Lactose (India), Krebs Biochemicals and Industries, Asston Pharmaceuticals, BALAXI PHARMACEUTICALS, Parnax Lab.
Speciality Medicines, with a market cap of ₹136 Cr.
Godavari Drugs trades at a P/E of 24.2; the median of its peer set is 20.2. A P/E above or below the median is a description, not a judgement on value.
Godavari Drugs' return on capital employed is 7.0%, below the peer median of 10.0%.